National PKU News
www.pkunews.org

PKU Research

• Kuvan: On the Controversy that has Arisen over the Spring Issue’s Editorial
  from National PKU News, Volume 20, Number 2, Fall 2008

• BioMarin’s Kuvan is First FDA-Approved Drug for PKU
  from National PKU News, Volume 20, Number 1, Spring/Summer 2008

• The FDA Should Not have Approved Kuvan
  from National PKU News, Volume 20, Number 1, Spring/Summer 2008

• Message from the Editor of National PKU News regarding Kuvan’s FDA Approval
  from National PKU News, Volume 20, Number 1, Spring/Summer 2008

• Should I Try the New Drug? Weighing Risks versus Benefits

  Note: PDF files require Adobe Reader to be installed on your PC. If you do not have Adobe Reader installed on your PC,
  please click here to download Acrobat Reader for free.





• International Meeting Highlights Potential Breakthrough Treatments for PKU

• Meeting in Japan Highlights Research on NeoPhe in the Treatment of PKU

• Using Glycomacropeptide (GMP) for PKU Diet Treatment

• The Long Road to Developing a PKU Therapeutic

• BioMarin Announces that Kuvan Significantly Increases Phe Tolerance in BH4-Responsive PKU

• Essential Fatty Acids and the PKU Diet

• Using Large Neutral Amino Acids for PKU: A View from "Down Under"

• Questions and Answers about LNAA Use

• ADHD and PKU

• Fatty Acid Status Of Metabolic Patients: To Supplement Or Not To Supplement?

• BioMarin Forges Ahead with Research On PKU Diet Alternatives
• Will Tetrahydrobiopterin Have A Role In PKU Treatment?

• Results from the International Maternal PKU Study

• Can a Pill Partially Replace the PKU Diet?
  • Our Experience with PreKUnil Tablets
  • Commentary on PreKUnil Tablet Use
  • PreKUnil Tablets: Let's Be Cautious

• Ohio Conference Draws People from Thirty States and Seven Other Countries
  • Brain Phe and PKU
  • Phenylketonuria: The Irish Experience
  • ADHD and PKU

• Report on the Latest Scientific Developments in PKU

• Study Shows Long-Term Beneficial Effects of the PKU Diet, Even for Late-Diagnosed Persons